Amy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation, a wholly owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit organization. As the Chief Executive Officer, Amy has led the growth and development of this new subsidiary and is responsible for overall global regulatory strategy and implementation of research programs with a focus on the MDMA-assisted psychotherapy program within MAPS PBC. In this conversation we talk about her journey, and how she became one of leaders of MAPS's mission, about her past, her present and future. Tune in to hear more about the association, and how you can contribute to their amazing work. Enjoy!